RETA Overview
Upcoming Projects (RETA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (RETA)
-
Discussing the Long-term Open Label Extension Study of Larimar's Nomlabofusp for Friedreich’s Ataxia
Tickers: LRMR, BIIB, RETA
Executed On: Feb 11, 2025 at 10:00 AM EST -
A Second Look: Discussing Reata's SKYCLARYS (omaveloxolone) post FDA approval and the potential for competing Friedreich's Ataxia therapies
Ticker: RETA
Executed On: Mar 27, 2023 at 05:00 PM EDT -
Discussing Reata's SKYCLARYS (omaveloxolone) post FDA approval and the potential for competing Friedrich's Ataxia therapies
Tickers: RETA, LRMR
Executed On: Mar 06, 2023 at 03:00 PM EST -
Discussing Reata Pharma's Omaveloxolone in treating Friedreich's Ataxia
Ticker: RETA
Executed On: Feb 22, 2023 at 05:00 PM EST -
Diving into the FDA's concerns of Reata Pharma' s drug Omaveloxolone, in treating Friedreich’s Ataxia
Ticker: RETA
Executed On: Oct 14, 2022 at 03:30 PM EDT -
Discussing new treatments for FA with members of the Friedreich's Ataxia Research Alliance (FARA)
Ticker: RETA
Executed On: Feb 10, 2022 at 12:15 PM EST -
A Third Perspective: Analyzing Reata Pharma’s MOXIe study of omaveloxolone for the treatment of Friedreich's ataxia
Tickers: RETA, LRMR, DSGN
Executed On: Feb 09, 2022 at 03:00 PM EST -
A Second View: Analyzing Reata Pharma’s MOXIe study of omaveloxolone for the treatment of Friedreich's ataxia
Tickers: RETA, LRMR, DSGN
Executed On: Feb 08, 2022 at 10:00 AM EST -
Analyzing Reata Pharma’s MOXIe study of omaveloxolone for the treatment of Friedreich's ataxia
Ticker: RETA
Executed On: Feb 02, 2022 at 03:30 PM EST
Upcoming & Overdue Catalysts (RETA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (RETA)
-
Reata Pharmaceuticals Announces Interim Data From Extension Phase 2 LARIAT Study in Pulmonary Arterial Hypertension
Ticker: RETA
Occurred on: Jun 23, 2016
Strategic Initiatives (RETA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
